Medical Cannabis Market

Medical Cannabis Market, by Point of Sale, Active
Ingredient, and Therapeutic Application - Global Trends,
and Forecast to 2025
Medicinal cannabis are also known as Medical marijuana, which area used either to treat
disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol
(THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such
as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems,
and seizures. The various economies are involved in the activities to legalize the export of
medicinal cannabis product, which in turn is expected to fuel growth of the medical cannabis
market. For instance, in January 2018, the Government of Australia allowed cannabis producers
in the region to export medicinal cannabis and cannabis products in the global market.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/40
The global medical cannabis market is valued at US$ 3,520.7 million in 2017 and is expected
to witness a CAGR of 24.4% over the forecast period (2017 – 2025).
Market Dynamics:
According to the Medical Marijuana, Inc., an estimated size of the legal marijuana industry in
the U.S. was US$ 7.1 billion in 2016 with increase of 25% Y-o-Y. In 2016, 28 states in the U.S.
have legalized marijuana for medicinal purpose with some more gearing up for votes on the
recreational use of marijuana. California, Nevada, Maine, and Massachusetts states in November
2016, voted to legalize the recreational use of marijuana. The accelerated pace of legalization of
cannabis (marijuana) in the U.S. has attracted the attention of global investors in the medical
cannabis market. However, lack of formulation of a comprehensive law pertaining to medical
marijuana in some states inhibits patient access to the drug.
Legalization of medicinal cannabis in various economies is expected to drive the market growth:
Some of the major factors driving growth of the market include increasing approval of
medicinal cannabis products and increasing research and development activities. For instance, in
March 2017, a law that allows the use of cannabis plant was signed by the German parliament.
This would in turn allow the healthcare professionals to prescribe medicinal cannabis products
to the patients suffering from severe health issues such as chronic pain, vomiting, and nausea.
However, excessive consumption of cannabis will induce tachycardia, which will in turn
increase the risk of heart attack, especially for users who already suffer from heart disease or
arrhythmias. This is expected to hinder growth of the market.
Potential medical cannabis markets other than the U.S. include Canada, Israel, Australia, and
Spain. Mexico is also in process to consider the legalization of cannabis. For instance, in
February 2016, Medical Marijuana, Inc. launched the HempMeds Mexico- a CBD hemp oil
product in the Mexico. With the launch of HempMeds Mexico, company is intended to expand
its cannabis business in the Latin America, by establishing the labs, manufacturing, sales and
distribution facilities in the Mexico, in coming years. Other economies are expected to consider
legalization of the drug, once conclusive evidence regarding the safety and efficacy of cannabis
are obtained through extensive research. Czech Republic, in 2013, legalized medical marijuana
for patients suffering from chronic pain, epilepsy, chemotherapy induced side effects, and other
severe disease indications. Moreover, the law allows patients with marijuana prescription to
purchase the medicinal marijuana from pharmacies. However, cultivation of marijuana in not
allowed in the country, and thereby suppliers need to import medicinal cannabis from other
economies. This implies that there is a huge potential for growth of the medicinal cannabis
industry in pharmaceutical and biotechnology companies.
Report includes chapters which deeply display the following deliverable about industry :
• Medical Cannabis Market Research Objective and Assumption
• Medical Cannabis Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Medical Cannabis Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Medical Cannabis Market, By Regions
• Medical Cannabis Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Medical Cannabis Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Medical Cannabis Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Medical Cannabis Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Major Key Players:
Some of the key players operating in the global medical cannabis market include BOL Pharma,
Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys
Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, and
Medical Marijuana Inc.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/40
Market Taxonomy:
This report segments the global medicinal cannabis on the basis of point of sale, active
ingredient and therapeutic application. On the basis of point of sale, the global medical
cannabis market is classified into dispensaries, online pharmacy, and hospital pharmacy. Active
ingredients of medicinal cannabis include tetrahydrocannabinol (THC) and Cannabidiol (CBD).
Therapeutic Application categorized into pain, arthritis, neurological disease, and other
applications.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms.

Download Report